Health Canada DPD record: METHYLENE BLUE INJECTION USP, DIN 02230770, Juno Pharma Canada Inc., Montreal, 10 mg/mL intravenous, status Marketed (status date 5 November 2026), original market date 11 March 2001.
DIN : 02230770 Product Monograph/Veterinary Labelling: Date: 2026-11-05 Product monograph/Veterinary Labelling (PDF version ~ 175K) Company: JUNO PHARMA CANADA INC. 11177 Hamon Montreal Quebec Canada H3M 3E4 Class: Human Dosage form(s): Liquid Route(s) of administration: Intravenous
Health Canada DPD record: METHYLENE BLUE INJECTION USP, DIN 02230770, Juno Pharma Canada Inc., Montreal, 10 mg/mL intravenous, status Marketed (status date 5 November 2026), original market date 11 March 2001. C7 – Canadian record. Status and dates come from the DPD status API for drug_code 50032: status 'Marketed', history_date 2026-11-05, original_market_date 2001-03-11 (transcribed record fields; the excerpt itself is the DIN/company block from the HTML page). Full DPD brand list returned 11 DINs for 'methylene blue': only these two (02230770 Juno, 02487993 Phebra) are currently Marketed; 02302756 (Alveda) 'Cancelled (Unreturned Annual)' 2024-01-08; 02431548 (Hikma Canada) cancelled post-market 2026-01-20; older Glaxo/Sandoz/Mylan/Hospira/Rougier/David Bull DINs cancelled between 1996 and 2022. No Proveblue DIN. Fetch route: curl to health-products.canada.ca DPD API (drugproduct, status) and the HTML info page. Access date 2026-11-21, page undated: the date shown is the date this record page was read; the approval/status dates are the ones quoted from the page. Study type: regulatory record.
